Related Experiment Video
Updated: Jul 4, 2026
A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings
Axel R Pries1, Helmut Habazettl, Giuseppe Ambrosio
1Department of Physiology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Arnimallee 22, D-14195 Berlin, Germany.
Insights
Coronary microvascular disease (CMD) causes myocardial ischemia, even without blocked arteries, particularly in women. Further research into CMD is crucial for better diagnosis and treatment of ischemic heart disease.
Area of Science:
- Cardiology
- Vascular Biology
- Ischemic Heart Disease
Background:
- Obstructive coronary artery disease is a primary cause of angina pectoris.
- Angina can occur without significant coronary atherosclerosis or spasm, especially in women.
- Myocardial ischemia in these cases is often linked to coronary microcirculation abnormalities, suggesting coronary microvascular disease (CMD).
Purpose of the Study:
- To elucidate the role of the coronary microvasculature in myocardial ischemia and cardiac damage.
- To investigate the genesis of myocardial ischemia in the presence or absence of obstructive coronary atherosclerosis.
- To highlight the need for improved diagnostic and therapeutic strategies for ischemic heart disease patients, particularly those with CMD.
Main Methods:
- The abstract does not specify the methods used.
- Focuses on the conceptual understanding and need for research.
- Implies the need for improved assessment modalities for CMD diagnosis.
Main Results:
- Myocardial ischemia can occur due to abnormalities in the coronary microcirculation (CMD).
- CMD may manifest even in the absence of significant obstructive coronary atherosclerosis or vasospasm.
- Understanding microvascular dysfunction is key to addressing ischemic heart disease.
Conclusions:
- Elucidating the microvasculature's role in myocardial ischemia is vital for improved diagnostic and therapeutic interventions.
- Targeted research and advanced assessment modalities are needed to enhance CMD diagnosis.
- Translating current knowledge into novel therapeutic options for CMD is essential.
Abstract:
Obstructive disease of the large coronary arteries is the prominent cause for angina pectoris. However, angina may also occur in the absence of significant coronary atherosclerosis or coronary artery spasm, especially in women. Myocardial ischaemia in these patients is often associated with abnormalities of the coronary microcirculation and may thus represent a manifestation of coronary microvascular disease (CMD). Elucidation of the role of the microvasculature in the genesis of myocardial ischaemia and cardiac damage-in the presence or absence of obstructive coronary atherosclerosis-will certainly result in more rational diagnostic and therapeutic interventions for patients with ischaemic heart disease. Specifically targeted research based on improved assessment modalities is needed to improve the diagnosis of CMD and to translate current molecular, cellular, and physiological knowledge into new therapeutic options.
